Improvement of Cardiomyocyte Function by a Novel Pyrimidine-Based CaMKII-Inhibitor

OBJECTIVE: Pathologically increased activity of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and the associated Ca(2+)-leak from the sarcoplasmic reticulum are recognized to be important novel pharmacotherapeutic targets in heart failure and cardiac arrhythmias. However, CaMKII-inhibitory...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Mol Cell Cardiol
Hlavní autoři: Neef, Stefan, Steffens, Alexander, Pellicena, Patricia, Mustroph, Julian, Lebek, Simon, Ort, Katharina R., Schulman, Howard, Maier, Lars S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820112/
https://ncbi.nlm.nih.gov/pubmed/29294328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.12.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky